Helenvision Pure

Trade name

Helenvision Pure

05213010813484

803413527TD050PHTHLMCSLD3

Reference / catalog number

HYS277

GS1

Class IIb

Applicable legislation

MDR [Regulation (EU) 2017/745 on medical devices]

Status

On the market

Quantity

1

Additional product description

—

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

European Medical Device Nomenclature — the EU product classification assigned to this device.

• Q02030301OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES

3 warnings recorded — scroll inside the panel to see all entries.

• Ask your pharmacist or doctor for advice before using or taking the product (e.g. if pregnant or breastfeeding)
• Consult instructions for use
• Do not use if the container is damaged. • Do not use if you are sensitive to any of the components. • Do not use after the expiry date reported on the bottle and on the external package. • Do not touch the eye with the tip of the bottle. • After administration, in rare cases, a slight temporary blurring of vision may be observed. lt is therefore advisable to wait for a few seconds before any activity that requires clear vision. • Leave at least 10-15 minutes between administration of any other ophthalmic drugs for external use. • Discard the bottle 24 weeks after first opening. • Keep the product and its components out of the reach and sight of children. • Do not swallow. • The product is only for ophthalmic use. • Store at room temperature. • The product contains phosphates. ln some patients with significantly damaged corneas have been reported rare cases calcification of the cornea during the use of eye drops containing phosphates; it is therefore not recommended the use for patients with severe damage to the corneal surface (such as pronounced erosion or corneal ulcer). • Ιn case of pregnancy or breast feeding consult your doctor before using the product.

  OTHER